171 related articles for article (PubMed ID: 7510440)
1. Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning.
Chassot S; Lambert V; Kay A; Godinot C; Trepo C; Cova L
Virology; 1994 Apr; 200(1):72-8. PubMed ID: 7510440
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides.
Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L
Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
Miller DS; Kotlarski I; Jilbert AR
Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
5. In vivo selection of duck hepatitis B virus pre-S variants which escape from neutralization.
Sunyach C; Chassot S; Jamard C; Kay A; Trepo C; Cova L
Virology; 1997 Aug; 234(2):291-9. PubMed ID: 9268160
[TBL] [Abstract][Full Text] [Related]
6. Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein.
Lambert V; Fernholz D; Sprengel R; Fourel I; Deléage G; Wildner G; Peyret C; Trépo C; Cova L; Will H
J Virol; 1990 Mar; 64(3):1290-7. PubMed ID: 1689393
[TBL] [Abstract][Full Text] [Related]
7. Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation.
Khawaja G; Buronfosse T; Jamard C; Guerret S; Zoulim F; Luxembourg A; Hannaman D; Evans C; Hartmann D; Cova L
Virology; 2012 Mar; 425(1):61-9. PubMed ID: 22284894
[TBL] [Abstract][Full Text] [Related]
8. In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein.
Lambert V; Chassot S; Kay A; Trepo C; Cova L
Virology; 1991 Nov; 185(1):446-50. PubMed ID: 1718087
[TBL] [Abstract][Full Text] [Related]
9. Identification of T-cell epitopes associated with immunity within the surface protein of duck hepatitis B virus.
Welschinger R; Cossart Y; Pouliopoulos J; Dixon R; Vickery K
J Viral Hepat; 2006 Aug; 13(8):515-22. PubMed ID: 16901281
[TBL] [Abstract][Full Text] [Related]
10. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.
Milich DR; Jones JE; McLachlan A; Bitter G; Moriarty A; Hughes JL
J Immunol; 1990 May; 144(9):3544-51. PubMed ID: 1691763
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes.
Saade F; Buronfosse T; Pradat P; Abdul F; Cova L
Vaccine; 2008 Sep; 26(40):5159-64. PubMed ID: 18554756
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
13. Elimination of immune tolerance to hepatitis virus in an animal model.
Wen YM; Zhang W; Xu YY; Luo YF; Li PY
Chin Med J (Engl); 1992 Mar; 105(3):199-203. PubMed ID: 1395838
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune response of ducks to duck hepatitis B virus infection.
Vickery K; Cossart Y; Dixon R
J Med Virol; 1999 May; 58(1):19-25. PubMed ID: 10223541
[TBL] [Abstract][Full Text] [Related]
15. Recombinant vaccinia virus expressing Pre-S/S protein of duck hepatitis B virus and its preliminary use for treatment of persistent infection.
Ma ZM; Kong YY; Wang Y; Wen YM
Acta Virol; 1996; 40(5-6):311-4. PubMed ID: 9171461
[TBL] [Abstract][Full Text] [Related]
16. [Antisense oligodeoxynucleotide targeted at the pre-s region of DHBV could inhibit virus replication in vivo].
He L; Wu X; Chen C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):1-4. PubMed ID: 12515159
[TBL] [Abstract][Full Text] [Related]
17. The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines.
Feng F; Teoh CQ; Qiao Q; Boyle D; Jilbert AR
Vaccine; 2010 Oct; 28(46):7436-43. PubMed ID: 20833122
[TBL] [Abstract][Full Text] [Related]
18. Single B or T-cell epitope-based DNA vaccine using modified vector induces specific immune response against hepadnavirus.
Xu HB; Xu W; Chu YW; Wang Y; Xiong S
Immunol Lett; 2005 Jul; 99(2):186-92. PubMed ID: 16009269
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle.
Borel C; Sunyach C; Hantz O; Trepo C; Kay A
Virology; 1998 Mar; 242(1):90-8. PubMed ID: 9501048
[TBL] [Abstract][Full Text] [Related]
20. Development and application of the serological assay for humoral immune response against duck hepatitis B virus.
Tang N; Huang A; Guo S; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):13-5. PubMed ID: 11242126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
